{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:57:15Z","timestamp":1790704635294,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T00:00:00Z","timestamp":1464912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH","award":["P30 DK0909710551"],"award-info":[{"award-number":["P30 DK0909710551"]}]}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ebiom.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,6,5]],"date-time":"2016-06-05T15:40:59Z","timestamp":1465141259000},"page":"110-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors"],"prefix":"10.1016","volume":"9","author":[{"given":"Ami V.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Chaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangmin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Largaespada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish R.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2016.06.007_bb0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/leu.2010.249","article-title":"The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures","volume":"25","author":"Benedikt","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nmeth921","article-title":"shRNA libraries and their use in cancer genetics","volume":"3","author":"Bernards","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0020","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2007.05.018","article-title":"GEFs and GAPs: critical elements in the control of small G proteins","volume":"129","author":"Bos","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/path.2494","article-title":"Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours","volume":"217","author":"Bottillo","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0030","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrg2364","article-title":"The art and design of genetic screens: RNA interference","volume":"9","author":"Boutros","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0035","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1101\/gad.8.9.1019","article-title":"Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues","volume":"8","author":"Brannan","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ccr.2011.12.027","article-title":"Tumorigenic cells are common in mouse MPNSTs but their frequency depends upon tumor genotype and assay conditions","volume":"21","author":"Buchstaller","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0045","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ccr.2008.03.005","article-title":"Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells","volume":"13","author":"Chen","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nmeth913","article-title":"Enhancing and confirming the specificity of RNAi experiments","volume":"3","author":"Cullen","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0055","doi-asserted-by":"crossref","first-page":"25175","DOI":"10.18632\/oncotarget.4488","article-title":"Tumorigenesis by Meis1 overexpression is accompanied by a change of DNA target-sequence specificity which allows binding to the AP-1 element","volume":"6","author":"Dardaei","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature13561","article-title":"PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies","volume":"514","author":"De Raedt","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0092-8674(92)90407-4","article-title":"Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis","volume":"69","author":"Declue","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0070","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"Ducatman","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0075","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrc1947","article-title":"Lineage dependency and lineage-survival oncogenes in human cancer","volume":"6","author":"Garraway","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3835(03)00087-9","article-title":"The role of the MEIS homeobox genes in neuroblastoma","volume":"197","author":"Geerts","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0085","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression","volume":"25","author":"Giacinti","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0090","doi-asserted-by":"crossref","first-page":"19479","DOI":"10.1073\/pnas.0910398106","article-title":"PTEN dosage is essential for neurofibroma development and malignant transformation","volume":"106","author":"Gregorian","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0095","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.emboj.7600038","article-title":"Hematopoietic, angiogenic and eye defects in Meis1 mutant animals","volume":"23","author":"Hisa","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0100","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1101\/gad.258203","article-title":"The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development","volume":"17","author":"Jaegle","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2008.01.003","article-title":"The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells","volume":"13","author":"Joseph","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0110","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1017\/S1462399409001227","article-title":"Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways","volume":"11","author":"Katz","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/17460441.2015.974544","article-title":"Neuroblastoma models for insights into tumorigenesis and new therapies","volume":"10","author":"Kiyonari","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0120","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/blood-2008-06-163287","article-title":"A role for MEIS1 in MLL-fusion gene leukemia","volume":"113","author":"Kumar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0125","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1182\/blood-2010-01-264564","article-title":"Meis1 maintains stemness signature in MLL-AF9 leukemia","volume":"115","author":"Kumar","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ng.3095","article-title":"PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors","volume":"46","author":"Lee","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/gcc.2870100405","article-title":"TP53 mutations are frequent in malignant NF1 tumors","volume":"10","author":"Legius","year":"1994","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ng0293-122","article-title":"Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis","volume":"3","author":"Legius","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-4165(02)00189-7","article-title":"Down-regulation of Id-1 expression is associated with TGF beta 1-induced growth arrest in prostate epithelial cells","volume":"1570","author":"Ling","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0150","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/sj.onc.1204250","article-title":"Xmeis1, a protooncogene involved in specifying neural crest cell fate in Xenopus embryos","volume":"20","author":"Maeda","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0155","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.canlet.2014.10.035","article-title":"The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties","volume":"356","author":"Manrique","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0160","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10549-010-0810-6","article-title":"Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells","volume":"124","author":"Mern","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0165","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/emmm.200900027","article-title":"Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene","volume":"1","author":"Miller","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0170","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1158\/0008-5472.CAN-05-3330","article-title":"Large-scale molecular comparison of human Schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues","volume":"66","author":"Miller","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ng0296-149","article-title":"Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias","volume":"12","author":"Nakamura","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0180","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0002-9440(10)65507-1","article-title":"Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A\/p16 inactivation","volume":"155","author":"Nielsen","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0185","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/carcin\/23.5.721","article-title":"Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)\/pRB pathway","volume":"23","author":"Ouyang","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0190","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/1078-0432.CCR-12-1072","article-title":"Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target","volume":"18","author":"Patel","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/modpathol.2014.109","article-title":"Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas","volume":"28","author":"Pekmezci","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0200","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.celrep.2013.03.029","article-title":"Analysis of the DNA-binding profile and function of TALE homeoproteins reveals their specialization and specific interactions with Hox genes\/proteins","volume":"3","author":"Penkov","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0301-472X(01)00757-3","article-title":"Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny","volume":"30","author":"Pineault","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0210","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/ng.2641","article-title":"Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis","volume":"45","author":"Rahrmann","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2085","article-title":"Illuminating the silence: understanding the structure and function of small RNAs","volume":"8","author":"Rana","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0220","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0225","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM198710083171504","article-title":"Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung","volume":"317","author":"Rodenhuis","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0230","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0962-8924(03)00147-8","article-title":"Id proteins in development, cell cycle and cancer","volume":"13","author":"Ruzinova","year":"2003","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0235","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","article-title":"Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations","volume":"9","author":"Serra","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/cam4.19","article-title":"Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B","volume":"1","author":"Sharma","year":"2012","journal-title":"Cancer Med."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0245","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/geno.2000.6408","article-title":"The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32","volume":"71","author":"Spieker","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0250","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1158\/0008-5472.CAN-03-4079","article-title":"Comparative pathology of nerve sheath tumors in mouse models and humans","volume":"64","author":"Stemmer-Rachamimov","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0255","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2007-07-103010","article-title":"Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells","volume":"112","author":"Tam","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0260","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/MCB.21.1.224-234.2001","article-title":"Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia","volume":"21","author":"Thorsteinsdottir","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0265","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1182\/blood-2012-06-435800","article-title":"Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stress","volume":"120","author":"Unnisa","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0270","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1126\/science.286.5447.2176","article-title":"Mouse tumor model for neurofibromatosis type 1","volume":"286","author":"Vogel","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0275","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1750-3639.2004.tb00067.x","article-title":"Gene expression profiling reveals unique molecular subtypes of neurofibromatosis type I-associated and sporadic malignant peripheral nerve sheath tumors","volume":"14","author":"Watson","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0280","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1158\/2159-8290.CD-13-0081","article-title":"Canonical Wnt\/beta-catenin signaling drives human Schwann cell transformation, progression, and tumor maintenance","volume":"3","author":"Watson","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0285","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11912-009-0045-z","article-title":"Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors","volume":"11","author":"Widemann","year":"2009","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0290","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2007.12.027","article-title":"Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells","volume":"13","author":"Wu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0295","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.exphem.2010.06.006","article-title":"Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1","volume":"38","author":"Xiang","year":"2010","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0300","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jcp.10042","article-title":"Role of Id family proteins in growth control","volume":"190","author":"Yokota","year":"2002","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0305","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MCB.24.2.617-628.2004","article-title":"Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization","volume":"24","author":"Zeisig","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0310","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1101\/gad.1007602","article-title":"Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis","volume":"16","author":"Zhang","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0315","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ydbio.2006.06.030","article-title":"Pax6 is regulated by Meis and Pbx homeoproteins during pancreatic development","volume":"300","author":"Zhang","year":"2006","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0320","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.molonc.2013.07.011","article-title":"p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia","volume":"7","author":"Zhang","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0325","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1017\/S0031182011001788","article-title":"RNA interference in Caenorhabditis elegans: uptake, mechanism, and regulation","volume":"139","author":"Zhuang","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.ebiom.2016.06.007_bb0330","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nbt.1720","article-title":"Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi","volume":"29","author":"Zuber","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ebiom.2016.06.007_bb0335","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1101\/gad.17269211","article-title":"An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance","volume":"25","author":"Zuber","year":"2011","journal-title":"Genes Dev."}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2352396416302511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2352396416302511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T04:21:27Z","timestamp":1568002887000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396416302511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":67,"alternative-id":["S2352396416302511"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2016.06.007","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.ebiom.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}